cenexel
-
CenExel Creates Clinical Sciences Business Unit
CenExel announces a new Clinical Sciencesbusiness unit and more.
-
Brandy Isaacks Joins CenExel as Vice President of Project Management & Scientific Affairs
CNS Clinical Research Veteran Brings Extensive Expertise in Global Project Management & Operations
-
CenExel Acquires Apex Innovative Sciences
Premier CNS-Focused Research Facilities in California and New Jersey Join the CenExel Centers of Excellence Clinical Research Site…
-
CenExel Acquires iResearch
Premier CNS-Focused Research Facilities in Georgia Join the CenExel Centers of Excellence Clinical Research Site Network
-
CenExel Clinical Research Acquires Rocky Mountain Movement Disorders Center
Premier Neurology Facility in Colorado Joins the CenExel Centers of Excellence
-
CenExel Clinical Research Acquires California Neuroscience Research
CenExel Clinical Research, Inc. announced the acquisition of California Neuroscience Research.
-
CenExel Clinical Research Acquires Advanced Memory Research Institute
CenExel announces the acquisition of Advanced Memory Research Institute (“CenExel AMRI”), the largest Alzheimer’s Disease clinical research site…
-
CenExel Clinical Research Acquires ForCare Clinical Research
CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of ForCare Clinical Research (“CenExel FCR”), a Tampa-based clinical research…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
